SWOG - S1115

Trial

Clinical Trial Title

SWOG - S1115

Trial Status

Open to Enrollment

Start Date

February 22, 2013

Location

Trial Type

Cancer (Oncology)

Specific Condition

Metastatic Pancreatic

Description

A Randomized Phase II Clinical Trial of AZD6244 Hydrogen Sulfate (NSC-748727) and MK-2206 (NSC-749607) vs. mFOLFOX in Patients with Metastatic Pancreatic Cancer after Prior Chemotherapy

Eligibility Criteria

  • Patients must have histologically or cytologically confirmed diagnosis of pancreatic adenocarcinoma. Patients with endocrine or neuroendocrine tumors, lymphoma of the pancreas, or ampullary cancer are not eligible
  • Patients must have distant metastatic disease 
  • Patients must have received one line, and no more than one line, of prior gemcitabine chemotherapy for pancreatic cancer

IRB Number

IRB00009229

Notes

Sponsored by: SWOG Southwest Oncology Group

Principal Investigator Name

Jacqueline Vuky, MD

Contact Name

Legacy Oncology Clinical Research

Phone

503-413-8199

Contact Fax

503-431-6920

Last Updated: Wednesday, September 18, 2013 01:41:38 PM

We'd like to make your experience better.
x

Help us improve our site and be entered to win a $100 gift card.

Take the Survey